Varex Imaging Corp — Director's Dealing 2019

Nov 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Varex Imaging Corp (VREX)
CIK: 0001681622
Period of Report: 2019-11-01

Reporting Person: Jonaitis Mark S. (SVP and GM, X-Ray Sources)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-01	Common Stock	M	13530	$22.84	Acquired	51969	Direct
2019-11-01	Common Stock	S	13530	$31.02	Disposed	38439	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-01	Non-Qualified Stock Option (right to buy)	$22.84	M	13530	Disposed	2019-11-09	Common Stock (13530.0)	Direct

Footnotes

F1: Includes 939 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan.

F2: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on May 20, 2019. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.19 to $31.39. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F3: These options were granted in connection with the spin-off from Varian Medical Systems, Inc. and were immediately exercisable because they replaced Varian options that had previously vested.